BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31662557)

  • 1. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
    Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
    In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
    Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
    Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for advanced pelvic malignancy.
    Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
    Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total pelvic exenteration with preservation of fecal continence.
    Brodsky JT; Sloane BB; Khanna OP
    J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration.
    Lindsey WF; Wood DK; Briele HA; Greager JA; Walker MJ; Bork J; Das Gupta TK
    J Surg Oncol; 1985 Dec; 30(4):231-4. PubMed ID: 2417058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
    Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
    Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
    Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
    Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life.
    Quyn AJ; Solomon MJ; Lee PM; Badgery-Parker T; Masya LM; Young JM
    Dis Colon Rectum; 2016 Nov; 59(11):1005-1010. PubMed ID: 27749474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total pelvic exenteration. Apropos of 49 cases].
    Ranieri J; Tilliard JP
    Chirurgie; 1989; 115(1):48-56; discussion 57. PubMed ID: 2676419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgent Pelvic Exenteration: Should the Indication Be Extended?
    Thiptanakit C; Chowchankit I; Panya S; Kanjanasilp P; Malakorn S; Pattana-Arun J; Sahakitrungruang C
    Dis Colon Rectum; 2018 May; 61(5):561-566. PubMed ID: 29624550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pelvic exenteration for T4 rectal cancer: a series of 15 ressectable cases].
    Costa SR; Antunes RC; Paula RP; Pedroso MA; Farah JF; Lupinacci RA
    Arq Gastroenterol; 2007; 44(4):284-8. PubMed ID: 18317645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.